Mieke E.R. Henfling

1.4k citations

21 papers · 1.1k indexed · h-index 15

Co-authors: Frans C. S. Ramaekers Bert Schutte Manon van Engeland Chris Reutelingsperger Maurice J.B. van den Hoff Μ. Borgers Waander L. van Heerde Christl Vermeij‐Keers
Topics: Cell death mechanisms and regulation (5 papers)Ubiquitin and proteasome pathways (5 papers)Neuroendocrine Tumor Research Advances (4 papers)
Cited by: Otorhinolaryngology Oncology Cell Biology
Journals: PLoS ONE The Journal of Clinical Endocrinology & Metabolism Clinical Cancer Research
Partner nations: Netherlands Germany United States

In The Last Decade

Mieke E.R. Henfling

21 papers receiving 1.1k citations

Peers

Countries citing papers authored by Mieke E.R. Henfling

Since Specialization

Citations

This map shows the geographic impact of Mieke E.R. Henfling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mieke E.R. Henfling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mieke E.R. Henfling more than expected).

Fields of papers citing papers by Mieke E.R. Henfling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mieke E.R. Henfling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mieke E.R. Henfling. The network helps show where Mieke E.R. Henfling may publish in the future.

Co-authorship network of co-authors of Mieke E.R. Henfling

This figure shows the co-authorship network connecting the top 25 collaborators of Mieke E.R. Henfling. A scholar is included among the top collaborators of Mieke E.R. Henfling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mieke E.R. Henfling. Mieke E.R. Henfling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Switches of SOX17 and SOX2 expression in the development of squamous metaplasia and squamous intraepithelial lesions of the uterine cervix 2020 ·Cancer Medicine ·(unknown),(unknown),Monique Ummelen,Mieke E.R. Henfling,Manon van Engeland,Kristien Wouters,Hans Stoop,(unknown),Leendert H. J. Looijenga,Frans C. S. Ramaekers,Anton H. N. Hopman	9
2	SOX17 expression and its down‐regulation by promoter methylation in cervical adenocarcinoma in situ and adenocarcinoma 2019 ·Histopathology ·Anton H. N. Hopman,(unknown),(unknown),Monique Ummelen,Mieke E.R. Henfling,Manon van Engeland,Kristien Wouters,Hans Stoop,Leendert H. J. Looijenga,Frans C.�S. Ramaekers	16
3	The IGF pathway is activated in insulinomas but downregulated in metastatic disease 2018 ·Endocrine Related Cancer ·Mieke E.R. Henfling,Aurel Perren,Anja Schmitt,(unknown),(unknown),Robert G. Riedl,Yvonne M.H. Versleijen‐Jonkers,Diana Sprij-Mooij,Frans C. S. Ramaekers,Leo J. Hofland,Ernst‐Jan M. Speel	7
4	Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV‐negative tumors is an indicator of poor prognosis 2018 ·International Journal of Cancer ·Christian U. Huebbers,(unknown),(unknown),Nadine C. Olthof,Jutta Kolligs,Oliver Siefer,Mieke E.R. Henfling,Frans C. S. Ramaekers,Simon F. Preuss,Dirk Beutner,(unknown),Uta Drebber,Yüksel Korkmaz,Wan L. Lam,Emily A. Vucic,Bernd Kremer,Jens Peter Klußmann,Ernst‐Jan M. Speel	27
5	Comprehensive Analysis of HPV16 Integration in OSCC Reveals No Significant Impact of Physical Status on Viral Oncogene and Virally Disrupted Human Gene Expression 2014 ·PLoS ONE ·Nadine C. Olthof,Ernst‐Jan M. Speel,Jutta Kolligs,Annick Haesevoets,Mieke E.R. Henfling,Frans C. S. Ramaekers,Simon F. Preuss,Uta Drebber,Ulrike Wieland,Steffi Silling,Wan L. Lam,Emily A. Vucic,Bernd Kremer,Jens Peter Klußmann,Christian U. Huebbers	83
6	Viral load, gene expression and mapping of viral integration sites in HPV16‐associated HNSCC cell lines 2014 ·International Journal of Cancer ·Nadine C. Olthof,Christian U. Huebbers,Jutta Kolligs,Mieke E.R. Henfling,Frans C. S. Ramaekers,Iris Cornet,(unknown),Alexander P.A. Stegmann,Steffi Silling,Ulrike Wieland,Thomas E. Carey,Heather M. Walline,Susanne M. Gollin,Thomas K. Hoffmann,Johan de Winter,Bernd Kremer,Jens Peter Klußmann,Ernst‐Jan M. Speel	86
7	CD44 and OTP Are Strong Prognostic Markers for Pulmonary Carcinoids 2013 ·Clinical Cancer Research ·Dorian R.A. Swarts,Mieke E.R. Henfling,Leander Van Neste,Robert‐Jan van Suylen,Anne‐Marie C. Dingemans,Winand N.M. Dinjens,Annick Haesevoets,Martina Rudelius,Erik Thunnissen,Marco Volante,Wim Van Criekinge,Manon van Engeland,Frans C.�S. Ramaekers,Ernst‐Jan M. Speel	67
8	An exploration of pathways involved in lung carcinoid progression using gene expression profiling 2013 ·Carcinogenesis ·Dorian R.A. Swarts,Leander Van Neste,Mieke E.R. Henfling,(unknown),Paul P. Eijk,Marie‐Louise F. van Velthuysen,Aryan Vink,Marco Volante,Bauke Ylstra,Wim Van Criekinge,Manon van Engeland,Frans C. S. Ramaekers,Ernst‐Jan M. Speel	48
9	Dual roles of intermediate filaments in apoptosis 2007 ·Experimental Cell Research ·Normand Marceau,Bert Schutte,Stéphane Gilbert,Anne Loranger,Mieke E.R. Henfling,Jos L. V. Broers,(unknown),Frans C.�S. Ramaekers	62
10	DEDD association with cytokeratin filaments correlates with sensitivity to apoptosis 2006 ·APOPTOSIS ·Bert Schutte,Mieke E.R. Henfling,Frans C. S. Ramaekers	21
11	Proteasomes act in the pre-mitochondrial signal transduction route towards roscovitine-induced apoptosis 2004 ·International Journal of Oncology ·Mieke E.R. Henfling,F.C.S. Ramaekers,B. Schütte	5
12	Keratin 8/18 breakdown and reorganization during apoptosis 2004 ·Experimental Cell Research ·Bert Schutte,Mieke E.R. Henfling,Wendy Kölgen,(unknown),Steven J.R. Meex,Mathie P.G. Leers,Marius Nap,Viveka Björklund,(unknown),Bertil Björklund,E. Birgitte Lane,M. Bishr Omary,Hans Jörnvall,Frans C. S. Ramaekers	171
13	Inhibition of the cell cycle and induction of apoptosis by Noclosan and Loxat in cell lines irrespective of their origin. 2004 ·PubMed ·B. Schütte,(unknown),(unknown),Mieke E.R. Henfling,Monique Ummelen,(unknown),F.C.S. Ramaekers	1
14	Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation 2001 ·Journal of Cell Science ·Stefan M. van den Eijnde,Maurice J.B. van den Hoff,Chris Reutelingsperger,Waander L. van Heerde,Mieke E.R. Henfling,Christl Vermeij‐Keers,Bert Schutte,Μ. Borgers,Frans C. S. Ramaekers	245
15	The Effect of the Cyclin-Dependent Kinase Inhibitor Olomoucine on Cell Cycle Kinetics 1997 ·Experimental Cell Research ·Bert Schutte,(unknown),Manon van Engeland,Mieke E.R. Henfling,Laurent Meijer,Frans C. S. Ramaekers	93
16	Detailed analysis of cell cycle kinetics upon proteasome inhibition 1997 ·Cytometry ·Barbie M. Machiels,Mieke E.R. Henfling,Will L.H. Gerards,Jos L. V. Broers,H. Bloemendal,Frans C. S. Ramaekers,Bert Schutte	44
17	Detailed analysis of cell cycle kinetics upon proteasome inhibition 1997 ·Cytometry ·Barbie M. Machiels,Mieke E.R. Henfling,Will L.H. Gerards,Jos L. V. Broers,H. Bloemendal,Frans C.�S. Ramaekers,Bert Schutte	3
18	Changes in immunocytochemical detectability of proteasome epitopes depending on cell growth and fixation conditions of lung cancer cell lines. 1995 ·PubMed ·Barbie M. Machiels,Mieke E.R. Henfling,J. L. V. Broers,Klavs B. Hendil,F. C. S. Ramaekers	15
19	Age related resistance to experimental autoimmune myasthenia gravis in rats 1991 ·Journal of Autoimmunity ·Y. Graus,Mieke E.R. Henfling,Jan J.G.M. Verschuuren,Frank Spaans,H. Veldman,F.G.I. Jennekens,P. van Breda Vriesman,Marc De Baets	23
20	Accessory cell function of thoracic duct nonlymphoid cells, dendritic cells, and splenic adherent cells in the Brown-Norway rat 1985 ·Cellular Immunology ·Lex Nagelkerken,Mieke E.R. Henfling,Peter van Breda Vriesman	10

About Mieke E.R. Henfling

Mieke E.R. Henfling is a scholar working on Cell Biology, Neurology and Oncology, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (5 papers), Ubiquitin and proteasome pathways (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). The work is most often cited by research in Otorhinolaryngology (92 citations), Oncology (336 citations) and Cell Biology (198 citations). Mieke E.R. Henfling has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Frans C. S. Ramaekers, Bert Schutte, Manon van Engeland, Chris Reutelingsperger, Maurice J.B. van den Hoff, Μ. Borgers, Waander L. van Heerde, Christl Vermeij‐Keers, Stefan M. van den Eijnde and Ernst‐Jan M. Speel. Their work appears in journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact